EUVIMEDEUVIMED entdecken
Crossref

Dual Key‐Activated Nir‐I/II Fluorescence Probe for Monitoring Photodynamic and Photothermal Synergistic Therapy Efficacy

Wen-Xin Wang, Jing-Jing Chao, Zhi-Qing Wang, Ting Liu, Guo-Jiang Mao, Bin Yang, Chun-Yan Li iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202301230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Wen-Xin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Applications o…. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Hunan Provincial Innovation Foundation for Postgraduate.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As cancer markers, hydrogen peroxide (H 2 O 2 ) and viscosity play an essential role in the development of tumors. Meanwhile, based on the performance of near‐infrared (NIR) fluorescence imaging and the high efficiency of photodynamic therapy (PDT) and photothermal therapy (PTT) synergistic therapy, it is urgent to develop a dual‐key (H 2 O 2 and viscosity) activated fluorescence probe for cancer phototherapy. Herein, a NIR‐I/II fluorescence probe named BX‐B is reported. In the presence of both H 2 O 2 and viscosity, the fluorescence signal of NIR‐I (810 nm) and NIR‐II (945 nm) can be released. In the presence of H 2 O 2 , the PDT and PTT effects are observed. BX‐B is used to monitor its therapeutic effects in cancer cells and tumor‐bearing mice due to the increased viscosity caused by PDT and PTT. In addition, the tumors of mice treated with BX‐B are almost completely ablated after the laser irradiation based on its PDT and PTT synergistic therapy. This work provides a reliable platform for effective cancer treatment and immediate evaluation of therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNeoplasmsNanoparticlesAnimalsMicePhotothermal TherapyFluorescencePhototherapyCell Line, TumorPhotosensitizing Agents

Stichwörter der Autor:innen

hydrogen peroxidenear-infrared-I/II fluorescence probephotodynamic therapyphotothermal therapyviscosity

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, College of Chemistry, Xiangtan University, Xi…
  • Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions,…

ORCID-Profile: Chun-Yan Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Hunan Provincial Innovation Foundation for Postgraduate

Zitieren

APA

Wang, W. X., Chao, J. J., Wang, Z. Q., Liu, T., Mao, G. J., Yang, B., & Li, C. Y. (2023). Dual Key‐Activated Nir‐I/II Fluorescence Probe for Monitoring Photodynamic and Photothermal Synergistic Therapy Efficacy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301230

Vancouver

Wang WX, Chao JJ, Wang ZQ, Liu T, Mao GJ, Yang B, et al. Dual Key‐Activated Nir‐I/II Fluorescence Probe for Monitoring Photodynamic and Photothermal Synergistic Therapy Efficacy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301230

BibTeX
@article{Wang2023,
  author = {Wang, Wen-Xin and Chao, Jing-Jing and Wang, Zhi-Qing and Liu, Ting and Mao, Guo-Jiang and Yang, Bin and Li, Chun-Yan},
  title = {Dual Key‐Activated Nir‐I/II Fluorescence Probe for Monitoring Photodynamic and Photothermal Synergistic Therapy Efficacy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202301230}
}
Kostenlos starten →